Premium
DEFINING ULTRA‐HIGH‐RISK DLBCL PATIENTS PRIOR TO INITIAL TREATMENT BASED ON AN INTEGRATIVE HOST AND DISEASE PROGNOSTIC SCORE (FROM REMARC STUDY)
Author(s) -
Thieblemont C,
Deux J.F,
Vercellino L,
Chartier L,
Casasnovas O,
Judet A,
Baud V,
Tilly Hervé,
Cottereau A.S,
Meignan M
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.17_2879
Subject(s) - medicine , diffuse large b cell lymphoma , oncology , framingham risk score , proportional hazards model , performance status , gastroenterology , lymphoma , cancer , disease
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom